Defunct Company
Total Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
786
NCT01094821
Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers
Phase: Phase 1/2
Role: Collaborator
Start: Jan 31, 2005
Completion: Dec 31, 2005
NCT00389792
Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2006
Completion: Dec 31, 2008
NCT00431782
Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation
Start: Dec 31, 2006
Completion: Oct 31, 2007
NCT00630370
A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome
Start: Feb 29, 2008
Completion: Jul 31, 2008
NCT00691470
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
Phase: Phase 2/3
Start: May 31, 2008
Completion: Jun 30, 2009